nodes	percent_of_prediction	percent_of_DWPC	metapath
Aprepitant—CYP3A7—Docetaxel—head and neck cancer	0.106	0.209	CbGbCtD
Aprepitant—CYP3A7-CYP3A51P—Docetaxel—head and neck cancer	0.106	0.209	CbGbCtD
Aprepitant—CYP3A5—Docetaxel—head and neck cancer	0.0791	0.157	CbGbCtD
Aprepitant—CYP1A2—Fluorouracil—head and neck cancer	0.0771	0.153	CbGbCtD
Aprepitant—CYP2C9—Fluorouracil—head and neck cancer	0.0695	0.138	CbGbCtD
Aprepitant—CYP3A4—Vinblastine—head and neck cancer	0.0374	0.0741	CbGbCtD
Aprepitant—CYP3A4—Docetaxel—head and neck cancer	0.0309	0.0611	CbGbCtD
Aprepitant—TACR1—trigeminal nerve—head and neck cancer	0.0149	0.419	CbGeAlD
Aprepitant—TACR1—cranial nerve—head and neck cancer	0.0106	0.299	CbGeAlD
Aprepitant—TACR3—head—head and neck cancer	0.00334	0.0938	CbGeAlD
Aprepitant—Febrile neutropenia—Docetaxel—head and neck cancer	0.00237	0.00724	CcSEcCtD
Aprepitant—Polyp—Docetaxel—head and neck cancer	0.00234	0.00716	CcSEcCtD
Aprepitant—Deep vein thrombosis—Docetaxel—head and neck cancer	0.00234	0.00716	CcSEcCtD
Aprepitant—Oral candidiasis—Docetaxel—head and neck cancer	0.00224	0.00685	CcSEcCtD
Aprepitant—Disorientation—Hydroxyurea—head and neck cancer	0.00222	0.0068	CcSEcCtD
Aprepitant—Embolism—Docetaxel—head and neck cancer	0.00222	0.00678	CcSEcCtD
Aprepitant—TACR1—connective tissue—head and neck cancer	0.00219	0.0617	CbGeAlD
Aprepitant—Herpes simplex—Fluorouracil—head and neck cancer	0.00214	0.00654	CcSEcCtD
Aprepitant—Cyst—Docetaxel—head and neck cancer	0.00213	0.00651	CcSEcCtD
Aprepitant—Pharyngolaryngeal pain—Docetaxel—head and neck cancer	0.00211	0.00645	CcSEcCtD
Aprepitant—Laryngeal pain—Docetaxel—head and neck cancer	0.00209	0.00639	CcSEcCtD
Aprepitant—Dysarthria—Fluorouracil—head and neck cancer	0.00208	0.00638	CcSEcCtD
Aprepitant—Haemoglobin decreased—Docetaxel—head and neck cancer	0.00207	0.00633	CcSEcCtD
Aprepitant—Heartburn—Docetaxel—head and neck cancer	0.00207	0.00633	CcSEcCtD
Aprepitant—Blood creatinine increased—Hydroxyurea—head and neck cancer	0.00186	0.0057	CcSEcCtD
Aprepitant—TACR1—trachea—head and neck cancer	0.00184	0.0518	CbGeAlD
Aprepitant—Breast disorder—Hydroxyurea—head and neck cancer	0.0018	0.0055	CcSEcCtD
Aprepitant—Rigors—Docetaxel—head and neck cancer	0.00174	0.00533	CcSEcCtD
Aprepitant—Euphoric mood—Fluorouracil—head and neck cancer	0.00169	0.00518	CcSEcCtD
Aprepitant—Acute coronary syndrome—Vinblastine—head and neck cancer	0.00166	0.00507	CcSEcCtD
Aprepitant—Thrombophlebitis—Fluorouracil—head and neck cancer	0.00165	0.00506	CcSEcCtD
Aprepitant—Myocardial infarction—Vinblastine—head and neck cancer	0.00165	0.00504	CcSEcCtD
Aprepitant—Neuropathy peripheral—Vinblastine—head and neck cancer	0.00165	0.00504	CcSEcCtD
Aprepitant—Photosensitivity—Fluorouracil—head and neck cancer	0.00163	0.00499	CcSEcCtD
Aprepitant—Chest discomfort—Docetaxel—head and neck cancer	0.00161	0.00492	CcSEcCtD
Aprepitant—Dysuria—Hydroxyurea—head and neck cancer	0.00161	0.00492	CcSEcCtD
Aprepitant—Neutropenia—Hydroxyurea—head and neck cancer	0.00161	0.00492	CcSEcCtD
Aprepitant—Disorientation—Fluorouracil—head and neck cancer	0.0016	0.00489	CcSEcCtD
Aprepitant—Oropharyngeal pain—Docetaxel—head and neck cancer	0.00157	0.00479	CcSEcCtD
Aprepitant—Weight increased—Hydroxyurea—head and neck cancer	0.00156	0.00478	CcSEcCtD
Aprepitant—Infestation NOS—Hydroxyurea—head and neck cancer	0.00153	0.00469	CcSEcCtD
Aprepitant—Infestation—Hydroxyurea—head and neck cancer	0.00153	0.00469	CcSEcCtD
Aprepitant—Blood bilirubin increased—Docetaxel—head and neck cancer	0.0015	0.0046	CcSEcCtD
Aprepitant—Neuropathy peripheral—Hydroxyurea—head and neck cancer	0.0015	0.00459	CcSEcCtD
Aprepitant—Hypoaesthesia—Vinblastine—head and neck cancer	0.0015	0.00459	CcSEcCtD
Aprepitant—Pharyngitis—Vinblastine—head and neck cancer	0.0015	0.00458	CcSEcCtD
Aprepitant—Stomatitis—Hydroxyurea—head and neck cancer	0.00149	0.00457	CcSEcCtD
Aprepitant—Lethargy—Fluorouracil—head and neck cancer	0.00146	0.00447	CcSEcCtD
Aprepitant—Respiratory failure—Docetaxel—head and neck cancer	0.00145	0.00443	CcSEcCtD
Aprepitant—Osteoarthritis—Fluorouracil—head and neck cancer	0.00143	0.00438	CcSEcCtD
Aprepitant—Blood pressure increased—Docetaxel—head and neck cancer	0.00142	0.00435	CcSEcCtD
Aprepitant—Phosphatase alkaline increased—Docetaxel—head and neck cancer	0.00142	0.00435	CcSEcCtD
Aprepitant—Pulmonary embolism—Docetaxel—head and neck cancer	0.00142	0.00435	CcSEcCtD
Aprepitant—Hallucination—Hydroxyurea—head and neck cancer	0.00137	0.00419	CcSEcCtD
Aprepitant—Candida infection—Docetaxel—head and neck cancer	0.00136	0.00416	CcSEcCtD
Aprepitant—Alopecia—Vinblastine—head and neck cancer	0.00133	0.00408	CcSEcCtD
Aprepitant—TACR1—head—head and neck cancer	0.00129	0.0363	CbGeAlD
Aprepitant—Neoplasm—Docetaxel—head and neck cancer	0.00129	0.00394	CcSEcCtD
Aprepitant—Muscular weakness—Fluorouracil—head and neck cancer	0.00126	0.00386	CcSEcCtD
Aprepitant—Angiopathy—Hydroxyurea—head and neck cancer	0.00125	0.00382	CcSEcCtD
Aprepitant—Dysphagia—Fluorouracil—head and neck cancer	0.00124	0.00378	CcSEcCtD
Aprepitant—Chills—Hydroxyurea—head and neck cancer	0.00123	0.00378	CcSEcCtD
Aprepitant—Ill-defined disorder—Vinblastine—head and neck cancer	0.00122	0.00373	CcSEcCtD
Aprepitant—Alopecia—Hydroxyurea—head and neck cancer	0.00122	0.00372	CcSEcCtD
Aprepitant—Anaemia—Vinblastine—head and neck cancer	0.00121	0.00371	CcSEcCtD
Aprepitant—Erythema—Hydroxyurea—head and neck cancer	0.0012	0.00366	CcSEcCtD
Aprepitant—Thrombophlebitis—Docetaxel—head and neck cancer	0.00119	0.00365	CcSEcCtD
Aprepitant—Blood alkaline phosphatase increased—Docetaxel—head and neck cancer	0.00119	0.00363	CcSEcCtD
Aprepitant—Malaise—Vinblastine—head and neck cancer	0.00118	0.00362	CcSEcCtD
Aprepitant—Upper respiratory tract infection—Fluorouracil—head and neck cancer	0.00115	0.00352	CcSEcCtD
Aprepitant—Convulsion—Vinblastine—head and neck cancer	0.00114	0.00348	CcSEcCtD
Aprepitant—Hypertension—Vinblastine—head and neck cancer	0.00113	0.00347	CcSEcCtD
Aprepitant—Photosensitivity reaction—Fluorouracil—head and neck cancer	0.00113	0.00345	CcSEcCtD
Aprepitant—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.00111	0.0034	CcSEcCtD
Aprepitant—Pneumonia—Fluorouracil—head and neck cancer	0.00111	0.00339	CcSEcCtD
Aprepitant—Anaemia—Hydroxyurea—head and neck cancer	0.00111	0.00339	CcSEcCtD
Aprepitant—Discomfort—Vinblastine—head and neck cancer	0.0011	0.00338	CcSEcCtD
Aprepitant—Hot flush—Docetaxel—head and neck cancer	0.0011	0.00338	CcSEcCtD
Aprepitant—Infestation—Fluorouracil—head and neck cancer	0.0011	0.00337	CcSEcCtD
Aprepitant—Infestation NOS—Fluorouracil—head and neck cancer	0.0011	0.00337	CcSEcCtD
Aprepitant—Menopausal symptoms—Docetaxel—head and neck cancer	0.00109	0.00335	CcSEcCtD
Aprepitant—Acute coronary syndrome—Fluorouracil—head and neck cancer	0.00109	0.00333	CcSEcCtD
Aprepitant—Renal impairment—Docetaxel—head and neck cancer	0.00109	0.00332	CcSEcCtD
Aprepitant—Myocardial infarction—Fluorouracil—head and neck cancer	0.00108	0.00331	CcSEcCtD
Aprepitant—Neuropathy peripheral—Fluorouracil—head and neck cancer	0.00108	0.00331	CcSEcCtD
Aprepitant—Malaise—Hydroxyurea—head and neck cancer	0.00108	0.0033	CcSEcCtD
Aprepitant—Stomatitis—Fluorouracil—head and neck cancer	0.00108	0.00329	CcSEcCtD
Aprepitant—Conjunctivitis—Fluorouracil—head and neck cancer	0.00107	0.00328	CcSEcCtD
Aprepitant—Urinary tract infection—Fluorouracil—head and neck cancer	0.00107	0.00328	CcSEcCtD
Aprepitant—Lethargy—Docetaxel—head and neck cancer	0.00105	0.00322	CcSEcCtD
Aprepitant—Thrombocytopenia—Vinblastine—head and neck cancer	0.00105	0.00321	CcSEcCtD
Aprepitant—Convulsion—Hydroxyurea—head and neck cancer	0.00104	0.00317	CcSEcCtD
Aprepitant—Hyponatraemia—Docetaxel—head and neck cancer	0.00104	0.00317	CcSEcCtD
Aprepitant—Anorexia—Vinblastine—head and neck cancer	0.00102	0.00312	CcSEcCtD
Aprepitant—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.00101	0.0031	CcSEcCtD
Aprepitant—Discomfort—Hydroxyurea—head and neck cancer	0.00101	0.00308	CcSEcCtD
Aprepitant—Hypoaesthesia—Fluorouracil—head and neck cancer	0.000985	0.00301	CcSEcCtD
Aprepitant—Pharyngitis—Fluorouracil—head and neck cancer	0.000983	0.00301	CcSEcCtD
Aprepitant—Oedema—Hydroxyurea—head and neck cancer	0.000977	0.00299	CcSEcCtD
Aprepitant—Infection—Hydroxyurea—head and neck cancer	0.000971	0.00297	CcSEcCtD
Aprepitant—Paraesthesia—Vinblastine—head and neck cancer	0.000962	0.00294	CcSEcCtD
Aprepitant—Dehydration—Docetaxel—head and neck cancer	0.000961	0.00294	CcSEcCtD
Aprepitant—Nervous system disorder—Hydroxyurea—head and neck cancer	0.000959	0.00293	CcSEcCtD
Aprepitant—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.000957	0.00293	CcSEcCtD
Aprepitant—Skin disorder—Hydroxyurea—head and neck cancer	0.000949	0.0029	CcSEcCtD
Aprepitant—Abdominal pain upper—Docetaxel—head and neck cancer	0.000944	0.00289	CcSEcCtD
Aprepitant—Breast disorder—Docetaxel—head and neck cancer	0.000934	0.00286	CcSEcCtD
Aprepitant—Anorexia—Hydroxyurea—head and neck cancer	0.000932	0.00285	CcSEcCtD
Aprepitant—Decreased appetite—Vinblastine—head and neck cancer	0.000932	0.00285	CcSEcCtD
Aprepitant—Cramp muscle—Docetaxel—head and neck cancer	0.00093	0.00285	CcSEcCtD
Aprepitant—Toxic epidermal necrolysis—Docetaxel—head and neck cancer	0.00093	0.00285	CcSEcCtD
Aprepitant—Aspartate aminotransferase increased—Docetaxel—head and neck cancer	0.00093	0.00285	CcSEcCtD
Aprepitant—Pain—Vinblastine—head and neck cancer	0.000917	0.0028	CcSEcCtD
Aprepitant—Constipation—Vinblastine—head and neck cancer	0.000917	0.0028	CcSEcCtD
Aprepitant—Alanine aminotransferase increased—Docetaxel—head and neck cancer	0.000911	0.00279	CcSEcCtD
Aprepitant—TACR1—lymph node—head and neck cancer	0.000904	0.0254	CbGeAlD
Aprepitant—Dysphagia—Docetaxel—head and neck cancer	0.000893	0.00273	CcSEcCtD
Aprepitant—Feeling abnormal—Vinblastine—head and neck cancer	0.000883	0.0027	CcSEcCtD
Aprepitant—Gastrointestinal pain—Vinblastine—head and neck cancer	0.000876	0.00268	CcSEcCtD
Aprepitant—Alopecia—Fluorouracil—head and neck cancer	0.000875	0.00268	CcSEcCtD
Aprepitant—Dyspnoea—Hydroxyurea—head and neck cancer	0.000871	0.00267	CcSEcCtD
Aprepitant—Somnolence—Hydroxyurea—head and neck cancer	0.000869	0.00266	CcSEcCtD
Aprepitant—Erythema—Fluorouracil—head and neck cancer	0.000862	0.00264	CcSEcCtD
Aprepitant—Dyspepsia—Hydroxyurea—head and neck cancer	0.00086	0.00263	CcSEcCtD
Aprepitant—Decreased appetite—Hydroxyurea—head and neck cancer	0.00085	0.0026	CcSEcCtD
Aprepitant—Abdominal pain—Vinblastine—head and neck cancer	0.000847	0.00259	CcSEcCtD
Aprepitant—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.000844	0.00258	CcSEcCtD
Aprepitant—Fatigue—Hydroxyurea—head and neck cancer	0.000843	0.00258	CcSEcCtD
Aprepitant—Pain—Hydroxyurea—head and neck cancer	0.000836	0.00256	CcSEcCtD
Aprepitant—Constipation—Hydroxyurea—head and neck cancer	0.000836	0.00256	CcSEcCtD
Aprepitant—Neutropenia—Docetaxel—head and neck cancer	0.000835	0.00255	CcSEcCtD
Aprepitant—Weight increased—Docetaxel—head and neck cancer	0.000813	0.00249	CcSEcCtD
Aprepitant—Weight decreased—Docetaxel—head and neck cancer	0.000808	0.00247	CcSEcCtD
Aprepitant—Feeling abnormal—Hydroxyurea—head and neck cancer	0.000805	0.00246	CcSEcCtD
Aprepitant—Pneumonia—Docetaxel—head and neck cancer	0.000801	0.00245	CcSEcCtD
Aprepitant—Anaemia—Fluorouracil—head and neck cancer	0.000797	0.00244	CcSEcCtD
Aprepitant—Infestation NOS—Docetaxel—head and neck cancer	0.000796	0.00244	CcSEcCtD
Aprepitant—Infestation—Docetaxel—head and neck cancer	0.000796	0.00244	CcSEcCtD
Aprepitant—Hypersensitivity—Vinblastine—head and neck cancer	0.00079	0.00242	CcSEcCtD
Aprepitant—Stevens-Johnson syndrome—Docetaxel—head and neck cancer	0.000789	0.00241	CcSEcCtD
Aprepitant—Acute coronary syndrome—Docetaxel—head and neck cancer	0.000785	0.0024	CcSEcCtD
Aprepitant—Renal failure—Docetaxel—head and neck cancer	0.000783	0.00239	CcSEcCtD
Aprepitant—Neuropathy peripheral—Docetaxel—head and neck cancer	0.00078	0.00239	CcSEcCtD
Aprepitant—Myocardial infarction—Docetaxel—head and neck cancer	0.00078	0.00239	CcSEcCtD
Aprepitant—Stomatitis—Docetaxel—head and neck cancer	0.000776	0.00237	CcSEcCtD
Aprepitant—Conjunctivitis—Docetaxel—head and neck cancer	0.000774	0.00237	CcSEcCtD
Aprepitant—Body temperature increased—Hydroxyurea—head and neck cancer	0.000773	0.00236	CcSEcCtD
Aprepitant—Asthenia—Vinblastine—head and neck cancer	0.000769	0.00235	CcSEcCtD
Aprepitant—Convulsion—Fluorouracil—head and neck cancer	0.000747	0.00228	CcSEcCtD
Aprepitant—Myalgia—Fluorouracil—head and neck cancer	0.000734	0.00224	CcSEcCtD
Aprepitant—Chest pain—Fluorouracil—head and neck cancer	0.000734	0.00224	CcSEcCtD
Aprepitant—Diarrhoea—Vinblastine—head and neck cancer	0.000733	0.00224	CcSEcCtD
Aprepitant—Discomfort—Fluorouracil—head and neck cancer	0.000725	0.00222	CcSEcCtD
Aprepitant—Hypersensitivity—Hydroxyurea—head and neck cancer	0.00072	0.0022	CcSEcCtD
Aprepitant—Hypoaesthesia—Docetaxel—head and neck cancer	0.000711	0.00218	CcSEcCtD
Aprepitant—Confusional state—Fluorouracil—head and neck cancer	0.000709	0.00217	CcSEcCtD
Aprepitant—Pharyngitis—Docetaxel—head and neck cancer	0.000709	0.00217	CcSEcCtD
Aprepitant—Dizziness—Vinblastine—head and neck cancer	0.000709	0.00217	CcSEcCtD
Aprepitant—Urinary tract disorder—Docetaxel—head and neck cancer	0.000706	0.00216	CcSEcCtD
Aprepitant—Oedema—Fluorouracil—head and neck cancer	0.000704	0.00215	CcSEcCtD
Aprepitant—Anaphylactic shock—Fluorouracil—head and neck cancer	0.000704	0.00215	CcSEcCtD
Aprepitant—Connective tissue disorder—Docetaxel—head and neck cancer	0.000702	0.00215	CcSEcCtD
Aprepitant—Asthenia—Hydroxyurea—head and neck cancer	0.000701	0.00214	CcSEcCtD
Aprepitant—Urethral disorder—Docetaxel—head and neck cancer	0.000701	0.00214	CcSEcCtD
Aprepitant—Infection—Fluorouracil—head and neck cancer	0.000699	0.00214	CcSEcCtD
Aprepitant—Nervous system disorder—Fluorouracil—head and neck cancer	0.00069	0.00211	CcSEcCtD
Aprepitant—CYP3A7—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.00069	0.00521	CbGpPWpGaD
Aprepitant—Thrombocytopenia—Fluorouracil—head and neck cancer	0.000689	0.00211	CcSEcCtD
Aprepitant—Tachycardia—Fluorouracil—head and neck cancer	0.000687	0.0021	CcSEcCtD
Aprepitant—Vomiting—Vinblastine—head and neck cancer	0.000681	0.00208	CcSEcCtD
Aprepitant—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—head and neck cancer	0.000676	0.00511	CbGpPWpGaD
Aprepitant—Erythema multiforme—Docetaxel—head and neck cancer	0.000676	0.00207	CcSEcCtD
Aprepitant—TACR1—Spinal Cord Injury—PTGS2—head and neck cancer	0.000674	0.00509	CbGpPWpGaD
Aprepitant—Headache—Vinblastine—head and neck cancer	0.000671	0.00205	CcSEcCtD
Aprepitant—Anorexia—Fluorouracil—head and neck cancer	0.000671	0.00205	CcSEcCtD
Aprepitant—Diarrhoea—Hydroxyurea—head and neck cancer	0.000669	0.00205	CcSEcCtD
Aprepitant—Eye disorder—Docetaxel—head and neck cancer	0.000668	0.00204	CcSEcCtD
Aprepitant—Flushing—Docetaxel—head and neck cancer	0.000663	0.00203	CcSEcCtD
Aprepitant—Cardiac disorder—Docetaxel—head and neck cancer	0.000663	0.00203	CcSEcCtD
Aprepitant—Hypotension—Fluorouracil—head and neck cancer	0.000657	0.00201	CcSEcCtD
Aprepitant—CYP3A4—Estrogen metabolism—GSTM1—head and neck cancer	0.000649	0.0049	CbGpPWpGaD
Aprepitant—Angiopathy—Docetaxel—head and neck cancer	0.000648	0.00198	CcSEcCtD
Aprepitant—Dizziness—Hydroxyurea—head and neck cancer	0.000646	0.00198	CcSEcCtD
Aprepitant—Immune system disorder—Docetaxel—head and neck cancer	0.000646	0.00197	CcSEcCtD
Aprepitant—Mediastinal disorder—Docetaxel—head and neck cancer	0.000644	0.00197	CcSEcCtD
Aprepitant—CYP3A7—Biological oxidations—NAT2—head and neck cancer	0.000643	0.00486	CbGpPWpGaD
Aprepitant—Chills—Docetaxel—head and neck cancer	0.000641	0.00196	CcSEcCtD
Aprepitant—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.000641	0.00196	CcSEcCtD
Aprepitant—Nausea—Vinblastine—head and neck cancer	0.000637	0.00195	CcSEcCtD
Aprepitant—TACR3—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—head and neck cancer	0.000637	0.00481	CbGpPWpGaD
Aprepitant—Insomnia—Fluorouracil—head and neck cancer	0.000636	0.00195	CcSEcCtD
Aprepitant—CYP3A7—Metapathway biotransformation—NAT2—head and neck cancer	0.000634	0.00479	CbGpPWpGaD
Aprepitant—Paraesthesia—Fluorouracil—head and neck cancer	0.000632	0.00193	CcSEcCtD
Aprepitant—Alopecia—Docetaxel—head and neck cancer	0.000632	0.00193	CcSEcCtD
Aprepitant—Dyspnoea—Fluorouracil—head and neck cancer	0.000627	0.00192	CcSEcCtD
Aprepitant—Mental disorder—Docetaxel—head and neck cancer	0.000626	0.00192	CcSEcCtD
Aprepitant—Somnolence—Fluorouracil—head and neck cancer	0.000625	0.00191	CcSEcCtD
Aprepitant—TACR1—Spinal Cord Injury—IL2—head and neck cancer	0.000625	0.00472	CbGpPWpGaD
Aprepitant—Malnutrition—Docetaxel—head and neck cancer	0.000622	0.0019	CcSEcCtD
Aprepitant—Erythema—Docetaxel—head and neck cancer	0.000622	0.0019	CcSEcCtD
Aprepitant—Vomiting—Hydroxyurea—head and neck cancer	0.000621	0.0019	CcSEcCtD
Aprepitant—Dyspepsia—Fluorouracil—head and neck cancer	0.000619	0.00189	CcSEcCtD
Aprepitant—TACR3—Signaling Pathways—KISS1—head and neck cancer	0.000617	0.00466	CbGpPWpGaD
Aprepitant—Rash—Hydroxyurea—head and neck cancer	0.000616	0.00189	CcSEcCtD
Aprepitant—Dermatitis—Hydroxyurea—head and neck cancer	0.000616	0.00188	CcSEcCtD
Aprepitant—CYP3A4—Estrogen metabolism—CYP1A1—head and neck cancer	0.000616	0.00465	CbGpPWpGaD
Aprepitant—Headache—Hydroxyurea—head and neck cancer	0.000612	0.00187	CcSEcCtD
Aprepitant—Decreased appetite—Fluorouracil—head and neck cancer	0.000612	0.00187	CcSEcCtD
Aprepitant—Dysgeusia—Docetaxel—head and neck cancer	0.000609	0.00186	CcSEcCtD
Aprepitant—TACR1—Spinal Cord Injury—CCND1—head and neck cancer	0.000609	0.0046	CbGpPWpGaD
Aprepitant—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.000607	0.00186	CcSEcCtD
Aprepitant—TACR3—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—head and neck cancer	0.000606	0.00458	CbGpPWpGaD
Aprepitant—TACR3—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—head and neck cancer	0.000606	0.00457	CbGpPWpGaD
Aprepitant—Back pain—Docetaxel—head and neck cancer	0.000602	0.00184	CcSEcCtD
Aprepitant—Pain—Fluorouracil—head and neck cancer	0.000602	0.00184	CcSEcCtD
Aprepitant—Muscle spasms—Docetaxel—head and neck cancer	0.000598	0.00183	CcSEcCtD
Aprepitant—TACR3—G alpha (q) signalling events—PIK3CA—head and neck cancer	0.000588	0.00444	CbGpPWpGaD
Aprepitant—Nausea—Hydroxyurea—head and neck cancer	0.000581	0.00178	CcSEcCtD
Aprepitant—Feeling abnormal—Fluorouracil—head and neck cancer	0.00058	0.00177	CcSEcCtD
Aprepitant—Anaemia—Docetaxel—head and neck cancer	0.000575	0.00176	CcSEcCtD
Aprepitant—CYP3A7—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000567	0.00428	CbGpPWpGaD
Aprepitant—CYP3A4—Xenobiotics—CYP1A1—head and neck cancer	0.000566	0.00427	CbGpPWpGaD
Aprepitant—TACR1—GPCR downstream signaling—KISS1—head and neck cancer	0.000561	0.00424	CbGpPWpGaD
Aprepitant—Urticaria—Fluorouracil—head and neck cancer	0.000559	0.00171	CcSEcCtD
Aprepitant—Syncope—Docetaxel—head and neck cancer	0.000558	0.00171	CcSEcCtD
Aprepitant—Body temperature increased—Fluorouracil—head and neck cancer	0.000556	0.0017	CcSEcCtD
Aprepitant—Palpitations—Docetaxel—head and neck cancer	0.00055	0.00168	CcSEcCtD
Aprepitant—Loss of consciousness—Docetaxel—head and neck cancer	0.000547	0.00167	CcSEcCtD
Aprepitant—CYP1A2—Melatonin metabolism and effects—CYP1A1—head and neck cancer	0.000545	0.00411	CbGpPWpGaD
Aprepitant—CYP3A4—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.000544	0.00411	CbGpPWpGaD
Aprepitant—Cough—Docetaxel—head and neck cancer	0.000543	0.00166	CcSEcCtD
Aprepitant—Convulsion—Docetaxel—head and neck cancer	0.000539	0.00165	CcSEcCtD
Aprepitant—Hypertension—Docetaxel—head and neck cancer	0.000537	0.00164	CcSEcCtD
Aprepitant—Myalgia—Docetaxel—head and neck cancer	0.00053	0.00162	CcSEcCtD
Aprepitant—Chest pain—Docetaxel—head and neck cancer	0.00053	0.00162	CcSEcCtD
Aprepitant—Arthralgia—Docetaxel—head and neck cancer	0.00053	0.00162	CcSEcCtD
Aprepitant—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.000526	0.00161	CcSEcCtD
Aprepitant—TACR3—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—head and neck cancer	0.000526	0.00397	CbGpPWpGaD
Aprepitant—Hypersensitivity—Fluorouracil—head and neck cancer	0.000518	0.00159	CcSEcCtD
Aprepitant—Dry mouth—Docetaxel—head and neck cancer	0.000518	0.00158	CcSEcCtD
Aprepitant—Confusional state—Docetaxel—head and neck cancer	0.000512	0.00157	CcSEcCtD
Aprepitant—TACR1—Signaling by GPCR—KISS1—head and neck cancer	0.00051	0.00385	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—GRP—head and neck cancer	0.000508	0.00384	CbGpPWpGaD
Aprepitant—Oedema—Docetaxel—head and neck cancer	0.000508	0.00155	CcSEcCtD
Aprepitant—Anaphylactic shock—Docetaxel—head and neck cancer	0.000508	0.00155	CcSEcCtD
Aprepitant—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000505	0.00382	CbGpPWpGaD
Aprepitant—Infection—Docetaxel—head and neck cancer	0.000504	0.00154	CcSEcCtD
Aprepitant—TACR1—Spinal Cord Injury—MAPK3—head and neck cancer	0.000502	0.00379	CbGpPWpGaD
Aprepitant—Shock—Docetaxel—head and neck cancer	0.0005	0.00153	CcSEcCtD
Aprepitant—CYP3A5—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000499	0.00377	CbGpPWpGaD
Aprepitant—Nervous system disorder—Docetaxel—head and neck cancer	0.000498	0.00152	CcSEcCtD
Aprepitant—Pruritus—Fluorouracil—head and neck cancer	0.000498	0.00152	CcSEcCtD
Aprepitant—Thrombocytopenia—Docetaxel—head and neck cancer	0.000497	0.00152	CcSEcCtD
Aprepitant—Tachycardia—Docetaxel—head and neck cancer	0.000496	0.00152	CcSEcCtD
Aprepitant—Skin disorder—Docetaxel—head and neck cancer	0.000493	0.00151	CcSEcCtD
Aprepitant—TACR3—Signaling Pathways—STAT6—head and neck cancer	0.000493	0.00372	CbGpPWpGaD
Aprepitant—TACR3—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—head and neck cancer	0.000486	0.00367	CbGpPWpGaD
Aprepitant—Anorexia—Docetaxel—head and neck cancer	0.000484	0.00148	CcSEcCtD
Aprepitant—Diarrhoea—Fluorouracil—head and neck cancer	0.000481	0.00147	CcSEcCtD
Aprepitant—CYP1A2—Estrogen Receptor Pathway—STAT3—head and neck cancer	0.00048	0.00363	CbGpPWpGaD
Aprepitant—CYP1A2—Phase II conjugation—NAT2—head and neck cancer	0.000479	0.00362	CbGpPWpGaD
Aprepitant—TACR1—Spinal Cord Injury—MAPK1—head and neck cancer	0.000478	0.00361	CbGpPWpGaD
Aprepitant—TACR1—Spinal Cord Injury—EGFR—head and neck cancer	0.000478	0.00361	CbGpPWpGaD
Aprepitant—Hypotension—Docetaxel—head and neck cancer	0.000474	0.00145	CcSEcCtD
Aprepitant—Dizziness—Fluorouracil—head and neck cancer	0.000465	0.00142	CcSEcCtD
Aprepitant—CYP3A5—Biological oxidations—NAT2—head and neck cancer	0.000465	0.00351	CbGpPWpGaD
Aprepitant—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.000463	0.00142	CcSEcCtD
Aprepitant—TACR1—GPCR downstream signaling—GRP—head and neck cancer	0.000462	0.00349	CbGpPWpGaD
Aprepitant—Insomnia—Docetaxel—head and neck cancer	0.000459	0.0014	CcSEcCtD
Aprepitant—CYP3A5—Metapathway biotransformation—NAT2—head and neck cancer	0.000458	0.00346	CbGpPWpGaD
Aprepitant—CYP2C19—Arachidonic acid metabolism—GPX1—head and neck cancer	0.000457	0.00345	CbGpPWpGaD
Aprepitant—Paraesthesia—Docetaxel—head and neck cancer	0.000456	0.00139	CcSEcCtD
Aprepitant—CYP1A2—thyroid gland—head and neck cancer	0.000454	0.0128	CbGeAlD
Aprepitant—Dyspnoea—Docetaxel—head and neck cancer	0.000453	0.00138	CcSEcCtD
Aprepitant—CYP2C19—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.000452	0.00341	CbGpPWpGaD
Aprepitant—Somnolence—Docetaxel—head and neck cancer	0.000451	0.00138	CcSEcCtD
Aprepitant—Vomiting—Fluorouracil—head and neck cancer	0.000447	0.00137	CcSEcCtD
Aprepitant—Dyspepsia—Docetaxel—head and neck cancer	0.000447	0.00137	CcSEcCtD
Aprepitant—Rash—Fluorouracil—head and neck cancer	0.000444	0.00136	CcSEcCtD
Aprepitant—Dermatitis—Fluorouracil—head and neck cancer	0.000443	0.00136	CcSEcCtD
Aprepitant—Decreased appetite—Docetaxel—head and neck cancer	0.000441	0.00135	CcSEcCtD
Aprepitant—Headache—Fluorouracil—head and neck cancer	0.000441	0.00135	CcSEcCtD
Aprepitant—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.000438	0.00134	CcSEcCtD
Aprepitant—Fatigue—Docetaxel—head and neck cancer	0.000438	0.00134	CcSEcCtD
Aprepitant—TACR3—Signaling Pathways—YAP1—head and neck cancer	0.000436	0.0033	CbGpPWpGaD
Aprepitant—Pain—Docetaxel—head and neck cancer	0.000434	0.00133	CcSEcCtD
Aprepitant—Constipation—Docetaxel—head and neck cancer	0.000434	0.00133	CcSEcCtD
Aprepitant—TACR1—SIDS Susceptibility Pathways—VEGFA—head and neck cancer	0.000425	0.00321	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—GRP—head and neck cancer	0.00042	0.00317	CbGpPWpGaD
Aprepitant—Feeling abnormal—Docetaxel—head and neck cancer	0.000418	0.00128	CcSEcCtD
Aprepitant—Nausea—Fluorouracil—head and neck cancer	0.000418	0.00128	CcSEcCtD
Aprepitant—CYP2C9—Arachidonic acid metabolism—GPX1—head and neck cancer	0.000416	0.00315	CbGpPWpGaD
Aprepitant—Gastrointestinal pain—Docetaxel—head and neck cancer	0.000415	0.00127	CcSEcCtD
Aprepitant—CYP2C9—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.000412	0.00311	CbGpPWpGaD
Aprepitant—CYP3A5—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.00041	0.00309	CbGpPWpGaD
Aprepitant—Abdominal pain—Docetaxel—head and neck cancer	0.000401	0.00123	CcSEcCtD
Aprepitant—Body temperature increased—Docetaxel—head and neck cancer	0.000401	0.00123	CcSEcCtD
Aprepitant—TACR1—Spinal Cord Injury—TP53—head and neck cancer	0.000401	0.00303	CbGpPWpGaD
Aprepitant—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000391	0.00295	CbGpPWpGaD
Aprepitant—CYP2C19—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000386	0.00291	CbGpPWpGaD
Aprepitant—CYP1A2—Tryptophan metabolism—CYP1A1—head and neck cancer	0.000377	0.00284	CbGpPWpGaD
Aprepitant—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—head and neck cancer	0.000377	0.00284	CbGpPWpGaD
Aprepitant—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—head and neck cancer	0.000377	0.00284	CbGpPWpGaD
Aprepitant—Hypersensitivity—Docetaxel—head and neck cancer	0.000374	0.00114	CcSEcCtD
Aprepitant—Asthenia—Docetaxel—head and neck cancer	0.000364	0.00111	CcSEcCtD
Aprepitant—CYP2C19—Biological oxidations—NAT2—head and neck cancer	0.000359	0.00271	CbGpPWpGaD
Aprepitant—Pruritus—Docetaxel—head and neck cancer	0.000359	0.0011	CcSEcCtD
Aprepitant—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000356	0.00269	CbGpPWpGaD
Aprepitant—CYP1A2—Arachidonic acid metabolism—GPX1—head and neck cancer	0.000356	0.00269	CbGpPWpGaD
Aprepitant—CYP2C19—Metapathway biotransformation—NAT2—head and neck cancer	0.000354	0.00268	CbGpPWpGaD
Aprepitant—CYP1A2—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.000352	0.00266	CbGpPWpGaD
Aprepitant—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000352	0.00266	CbGpPWpGaD
Aprepitant—Diarrhoea—Docetaxel—head and neck cancer	0.000347	0.00106	CcSEcCtD
Aprepitant—Dizziness—Docetaxel—head and neck cancer	0.000336	0.00103	CcSEcCtD
Aprepitant—CYP2C9—Biological oxidations—NAT2—head and neck cancer	0.000328	0.00248	CbGpPWpGaD
Aprepitant—CYP2C9—Metapathway biotransformation—NAT2—head and neck cancer	0.000323	0.00244	CbGpPWpGaD
Aprepitant—Vomiting—Docetaxel—head and neck cancer	0.000323	0.000988	CcSEcCtD
Aprepitant—Rash—Docetaxel—head and neck cancer	0.00032	0.000979	CcSEcCtD
Aprepitant—Dermatitis—Docetaxel—head and neck cancer	0.00032	0.000978	CcSEcCtD
Aprepitant—Headache—Docetaxel—head and neck cancer	0.000318	0.000973	CcSEcCtD
Aprepitant—CYP3A7—Biological oxidations—GSTM1—head and neck cancer	0.000318	0.0024	CbGpPWpGaD
Aprepitant—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000317	0.00239	CbGpPWpGaD
Aprepitant—CYP3A7—Metapathway biotransformation—GSTM1—head and neck cancer	0.000313	0.00237	CbGpPWpGaD
Aprepitant—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—head and neck cancer	0.000311	0.00235	CbGpPWpGaD
Aprepitant—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000304	0.0023	CbGpPWpGaD
Aprepitant—Nausea—Docetaxel—head and neck cancer	0.000302	0.000923	CcSEcCtD
Aprepitant—TACR1—Signaling Pathways—KISS1—head and neck cancer	0.000301	0.00228	CbGpPWpGaD
Aprepitant—CYP3A7—Biological oxidations—CYP1A1—head and neck cancer	0.000301	0.00227	CbGpPWpGaD
Aprepitant—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.0003	0.00227	CbGpPWpGaD
Aprepitant—CYP3A7—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000297	0.00224	CbGpPWpGaD
Aprepitant—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—head and neck cancer	0.000296	0.00223	CbGpPWpGaD
Aprepitant—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—head and neck cancer	0.000296	0.00223	CbGpPWpGaD
Aprepitant—CYP3A4—Tryptophan metabolism—CYP1A1—head and neck cancer	0.000291	0.0022	CbGpPWpGaD
Aprepitant—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000289	0.00218	CbGpPWpGaD
Aprepitant—TACR1—G alpha (q) signalling events—PIK3CA—head and neck cancer	0.000287	0.00217	CbGpPWpGaD
Aprepitant—CYP1A2—Biological oxidations—NAT2—head and neck cancer	0.00028	0.00212	CbGpPWpGaD
Aprepitant—CYP1A2—Metapathway biotransformation—NAT2—head and neck cancer	0.000276	0.00209	CbGpPWpGaD
Aprepitant—CYP2C19—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.000269	0.00203	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—UROD—head and neck cancer	0.000265	0.002	CbGpPWpGaD
Aprepitant—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—head and neck cancer	0.000257	0.00194	CbGpPWpGaD
Aprepitant—TACR3—GPCR downstream signaling—IL2—head and neck cancer	0.000252	0.00191	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—GRP—head and neck cancer	0.000248	0.00187	CbGpPWpGaD
Aprepitant—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000247	0.00186	CbGpPWpGaD
Aprepitant—CYP2C9—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.000245	0.00185	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—STAT6—head and neck cancer	0.000241	0.00182	CbGpPWpGaD
Aprepitant—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—head and neck cancer	0.000237	0.00179	CbGpPWpGaD
Aprepitant—CYP1A2—Phase II conjugation—GSTM1—head and neck cancer	0.000236	0.00179	CbGpPWpGaD
Aprepitant—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000235	0.00177	CbGpPWpGaD
Aprepitant—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000232	0.00175	CbGpPWpGaD
Aprepitant—CYP3A5—Biological oxidations—GSTM1—head and neck cancer	0.00023	0.00173	CbGpPWpGaD
Aprepitant—TACR3—Signaling by GPCR—IL2—head and neck cancer	0.000229	0.00173	CbGpPWpGaD
Aprepitant—CYP3A5—Metapathway biotransformation—GSTM1—head and neck cancer	0.000226	0.00171	CbGpPWpGaD
Aprepitant—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—head and neck cancer	0.000224	0.00169	CbGpPWpGaD
Aprepitant—CYP3A5—Biological oxidations—CYP1A1—head and neck cancer	0.000218	0.00164	CbGpPWpGaD
Aprepitant—CYP3A4—Biological oxidations—NAT2—head and neck cancer	0.000216	0.00163	CbGpPWpGaD
Aprepitant—CYP3A5—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000215	0.00162	CbGpPWpGaD
Aprepitant—CYP3A4—Metapathway biotransformation—NAT2—head and neck cancer	0.000213	0.00161	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—YAP1—head and neck cancer	0.000213	0.00161	CbGpPWpGaD
Aprepitant—CYP1A2—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.000209	0.00158	CbGpPWpGaD
Aprepitant—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—head and neck cancer	0.000208	0.00157	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—NOTCH1—head and neck cancer	0.000197	0.00149	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—UROD—head and neck cancer	0.000191	0.00145	CbGpPWpGaD
Aprepitant—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.00019	0.00144	CbGpPWpGaD
Aprepitant—TACR3—Signaling by GPCR—MAPK3—head and neck cancer	0.000184	0.00139	CbGpPWpGaD
Aprepitant—CYP2C19—Biological oxidations—GSTM1—head and neck cancer	0.000177	0.00134	CbGpPWpGaD
Aprepitant—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—head and neck cancer	0.000176	0.00133	CbGpPWpGaD
Aprepitant—TACR3—Signaling by GPCR—MAPK1—head and neck cancer	0.000175	0.00132	CbGpPWpGaD
Aprepitant—TACR3—Signaling by GPCR—EGFR—head and neck cancer	0.000175	0.00132	CbGpPWpGaD
Aprepitant—CYP2C19—Metapathway biotransformation—GSTM1—head and neck cancer	0.000175	0.00132	CbGpPWpGaD
Aprepitant—CYP2C19—Biological oxidations—CYP1A1—head and neck cancer	0.000168	0.00127	CbGpPWpGaD
Aprepitant—TACR3—GPCR downstream signaling—PIK3CA—head and neck cancer	0.000167	0.00127	CbGpPWpGaD
Aprepitant—CYP2C19—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000166	0.00125	CbGpPWpGaD
Aprepitant—CYP2C9—Biological oxidations—GSTM1—head and neck cancer	0.000162	0.00122	CbGpPWpGaD
Aprepitant—CYP2C9—Metapathway biotransformation—GSTM1—head and neck cancer	0.00016	0.00121	CbGpPWpGaD
Aprepitant—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—head and neck cancer	0.000159	0.0012	CbGpPWpGaD
Aprepitant—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—head and neck cancer	0.000159	0.0012	CbGpPWpGaD
Aprepitant—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—head and neck cancer	0.000159	0.0012	CbGpPWpGaD
Aprepitant—CYP2C9—Biological oxidations—CYP1A1—head and neck cancer	0.000153	0.00116	CbGpPWpGaD
Aprepitant—TACR3—Signaling by GPCR—PIK3CA—head and neck cancer	0.000152	0.00115	CbGpPWpGaD
Aprepitant—CYP2C9—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000151	0.00114	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—UROD—head and neck cancer	0.000148	0.00112	CbGpPWpGaD
Aprepitant—TACR3—Signaling by GPCR—HRAS—head and neck cancer	0.000141	0.00106	CbGpPWpGaD
Aprepitant—CYP1A2—Biological oxidations—GSTM1—head and neck cancer	0.000138	0.00104	CbGpPWpGaD
Aprepitant—TACR3—GPCR downstream signaling—AKT1—head and neck cancer	0.000137	0.00103	CbGpPWpGaD
Aprepitant—CYP1A2—Metapathway biotransformation—GSTM1—head and neck cancer	0.000136	0.00103	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—IL2—head and neck cancer	0.000135	0.00102	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—UROD—head and neck cancer	0.000135	0.00102	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—CCND1—head and neck cancer	0.000132	0.000997	CbGpPWpGaD
Aprepitant—CYP1A2—Biological oxidations—CYP1A1—head and neck cancer	0.000131	0.00099	CbGpPWpGaD
Aprepitant—CYP1A2—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000129	0.000977	CbGpPWpGaD
Aprepitant—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—head and neck cancer	0.000127	0.000963	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—PTEN—head and neck cancer	0.000127	0.000962	CbGpPWpGaD
Aprepitant—TACR3—Signaling by GPCR—AKT1—head and neck cancer	0.000124	0.000938	CbGpPWpGaD
Aprepitant—TACR1—GPCR downstream signaling—IL2—head and neck cancer	0.000123	0.000931	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—UROD—head and neck cancer	0.000115	0.000871	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—VEGFA—head and neck cancer	0.000115	0.000869	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.000115	0.000867	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—STAT3—head and neck cancer	0.000114	0.00086	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—IL2—head and neck cancer	0.000112	0.000845	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—NAT2—head and neck cancer	0.00011	0.000831	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—MAPK3—head and neck cancer	0.000109	0.000822	CbGpPWpGaD
Aprepitant—CYP3A4—Biological oxidations—GSTM1—head and neck cancer	0.000107	0.000806	CbGpPWpGaD
Aprepitant—CYP3A4—Metapathway biotransformation—GSTM1—head and neck cancer	0.000105	0.000795	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.000105	0.000791	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—MAPK1—head and neck cancer	0.000104	0.000782	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—EGFR—head and neck cancer	0.000104	0.000782	CbGpPWpGaD
Aprepitant—CYP3A4—Biological oxidations—CYP1A1—head and neck cancer	0.000101	0.000764	CbGpPWpGaD
Aprepitant—CYP3A4—Metapathway biotransformation—CYP1A1—head and neck cancer	9.98e-05	0.000754	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—DPYD—head and neck cancer	9.64e-05	0.000728	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—NOTCH1—head and neck cancer	9.6e-05	0.000726	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—YAP1—head and neck cancer	9.15e-05	0.000691	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—MAPK3—head and neck cancer	9e-05	0.00068	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—PIK3CA—head and neck cancer	8.98e-05	0.000679	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	8.95e-05	0.000676	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—UROD—head and neck cancer	8.9e-05	0.000672	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—TP53—head and neck cancer	8.69e-05	0.000657	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—MAPK1—head and neck cancer	8.56e-05	0.000647	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—EGFR—head and neck cancer	8.56e-05	0.000646	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—HRAS—head and neck cancer	8.31e-05	0.000628	CbGpPWpGaD
Aprepitant—TACR1—GPCR downstream signaling—PIK3CA—head and neck cancer	8.18e-05	0.000618	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—NAT2—head and neck cancer	7.95e-05	0.0006	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—PIK3CA—head and neck cancer	7.43e-05	0.000561	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—AKT1—head and neck cancer	7.34e-05	0.000554	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—DPYD—head and neck cancer	6.97e-05	0.000527	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—HRAS—head and neck cancer	6.87e-05	0.000519	CbGpPWpGaD
Aprepitant—TACR1—GPCR downstream signaling—AKT1—head and neck cancer	6.68e-05	0.000505	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—YAP1—head and neck cancer	6.61e-05	0.0005	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—IL2—head and neck cancer	6.61e-05	0.000499	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	6.53e-05	0.000493	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	6.46e-05	0.000488	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—CCND1—head and neck cancer	6.44e-05	0.000487	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—PTEN—head and neck cancer	6.22e-05	0.00047	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—NAT2—head and neck cancer	6.15e-05	0.000464	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—AKT1—head and neck cancer	6.07e-05	0.000458	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	5.95e-05	0.00045	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	5.89e-05	0.000445	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—VEGFA—head and neck cancer	5.62e-05	0.000424	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—NAT2—head and neck cancer	5.6e-05	0.000423	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—STAT3—head and neck cancer	5.56e-05	0.00042	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—TYMS—head and neck cancer	5.49e-05	0.000415	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—GSTM1—head and neck cancer	5.43e-05	0.00041	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—DPYD—head and neck cancer	5.39e-05	0.000407	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—MAPK3—head and neck cancer	5.31e-05	0.000401	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—GPX1—head and neck cancer	5.2e-05	0.000393	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—CYP1A1—head and neck cancer	5.15e-05	0.000389	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—YAP1—head and neck cancer	5.11e-05	0.000386	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	5.09e-05	0.000384	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—MAPK1—head and neck cancer	5.06e-05	0.000382	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—EGFR—head and neck cancer	5.06e-05	0.000382	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	5.03e-05	0.00038	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—DPYD—head and neck cancer	4.91e-05	0.000371	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—NAT2—head and neck cancer	4.79e-05	0.000362	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—YAP1—head and neck cancer	4.66e-05	0.000352	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—PIK3CA—head and neck cancer	4.39e-05	0.000331	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—TP53—head and neck cancer	4.24e-05	0.000321	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—DPYD—head and neck cancer	4.2e-05	0.000317	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—HRAS—head and neck cancer	4.06e-05	0.000307	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—YAP1—head and neck cancer	3.98e-05	0.000301	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—TYMS—head and neck cancer	3.97e-05	0.0003	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—GSTM1—head and neck cancer	3.93e-05	0.000297	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	3.84e-05	0.00029	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—GPX1—head and neck cancer	3.76e-05	0.000284	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—CYP1A1—head and neck cancer	3.72e-05	0.000281	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—NAT2—head and neck cancer	3.7e-05	0.000279	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—AKT1—head and neck cancer	3.58e-05	0.000271	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	3.5e-05	0.000265	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	3.35e-05	0.000253	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—DPYD—head and neck cancer	3.24e-05	0.000245	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—YAP1—head and neck cancer	3.07e-05	0.000232	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—TYMS—head and neck cancer	3.07e-05	0.000232	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—PTGS2—head and neck cancer	3.06e-05	0.000231	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	3.06e-05	0.000231	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—GSTM1—head and neck cancer	3.04e-05	0.000229	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	2.99e-05	0.000226	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—GPX1—head and neck cancer	2.91e-05	0.00022	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—CYP1A1—head and neck cancer	2.88e-05	0.000217	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—TYMS—head and neck cancer	2.8e-05	0.000211	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—GSTM1—head and neck cancer	2.77e-05	0.000209	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—PTEN—head and neck cancer	2.67e-05	0.000202	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—GPX1—head and neck cancer	2.65e-05	0.0002	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—CYP1A1—head and neck cancer	2.62e-05	0.000198	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	2.61e-05	0.000197	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—TYMS—head and neck cancer	2.39e-05	0.000181	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—GSTM1—head and neck cancer	2.36e-05	0.000179	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	2.36e-05	0.000179	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—GPX1—head and neck cancer	2.26e-05	0.000171	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—CYP1A1—head and neck cancer	2.24e-05	0.000169	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—PTGS2—head and neck cancer	2.21e-05	0.000167	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	2.16e-05	0.000163	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—PTEN—head and neck cancer	1.93e-05	0.000146	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—PIK3CA—head and neck cancer	1.88e-05	0.000142	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—TYMS—head and neck cancer	1.85e-05	0.000139	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.84e-05	0.000139	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—GSTM1—head and neck cancer	1.83e-05	0.000138	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—GPX1—head and neck cancer	1.75e-05	0.000132	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—CYP1A1—head and neck cancer	1.73e-05	0.000131	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—PTGS2—head and neck cancer	1.71e-05	0.000129	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—PTGS2—head and neck cancer	1.56e-05	0.000118	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—AKT1—head and neck cancer	1.54e-05	0.000116	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—PTEN—head and neck cancer	1.49e-05	0.000113	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—PIK3CA—head and neck cancer	1.36e-05	0.000103	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—PTEN—head and neck cancer	1.36e-05	0.000103	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—PTGS2—head and neck cancer	1.33e-05	0.000101	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—PTEN—head and neck cancer	1.16e-05	8.78e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—AKT1—head and neck cancer	1.11e-05	8.4e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—PIK3CA—head and neck cancer	1.05e-05	7.95e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—PTGS2—head and neck cancer	1.03e-05	7.77e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—PIK3CA—head and neck cancer	9.6e-06	7.25e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—PTEN—head and neck cancer	8.97e-06	6.78e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—AKT1—head and neck cancer	8.6e-06	6.5e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—PIK3CA—head and neck cancer	8.2e-06	6.2e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—AKT1—head and neck cancer	7.84e-06	5.92e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—AKT1—head and neck cancer	6.7e-06	5.06e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—PIK3CA—head and neck cancer	6.33e-06	4.78e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—AKT1—head and neck cancer	5.17e-06	3.91e-05	CbGpPWpGaD
